Extracellular signals in young and aging breast epithelial cells and possible connections to age-associated breast cancer development

Mechanisms of Ageing and Development

Volumn 132, Issue 5, 2011, Pages 213-219

  Chaturvedi, Sukhada ^a   Hass, Ralf ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Aging; Breast cancer; Extracellular matrix; MMP 7

Indexed keywords

ATM PROTEIN; ATR PROTEIN; BETA GALACTOSIDASE; COLLAGEN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; ELASTIN; EPIDERMAL GROWTH FACTOR RECEPTOR 4; FIBRONECTIN; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; HORMONE RECEPTOR; MATRILYSIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; REACTIVE OXYGEN METABOLITE; TENASCIN;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST EPITHELIUM; BREAST FIBROSIS; CANCER GROWTH; CELL AGING; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL INTERACTION; CELL POPULATION; CELL PROLIFERATION; CELL SURVIVAL; CHROMOSOME ABERRATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DAMAGE; ENZYME ACTIVATION; ENZYME ACTIVITY; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR SPACE; GENE EXPRESSION; GENE MUTATION; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TELOMERE; TUMOR MICROENVIRONMENT;

AGING; BREAST NEOPLASMS; CELL PROLIFERATION; CELL SIZE; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; FIBROSIS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MAMMARY GLANDS, HUMAN; MATRIX METALLOPROTEINASE 7;

EID: 79957757682     PISSN: 00476374     EISSN: 18726216     Source Type: Journal    
DOI: 10.1016/j.mad.2011.04.002     Document Type: Article

References (84)

1. Bakkenist C.J., Kastan M.B. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 2003, 421:499-506.
2. Bartholome A., Kampkotter A., Tanner S., Sies H., Klotz L.O. Epigallocatechin gallate-induced modulation of FoxO signaling in mammalian cells and C. elegans: FoxO stimulation is masked via PI3K/Akt activation by hydrogen peroxide formed in cell culture. Arch. Biochem. Biophys. 2010, 501:58-64.
3. Battula V.L., Evans K.W., Hollier B.G., Shi Y., Marini F.C., Ayyanan A., Wang R.Y., Brisken C., Guerra R., Andreeff M., Mani S.A. Epithelial-mesenchymal transition-derived cells exhibit multi-lineage differentiation potential similar to mesenchymal stem cells. Stem Cells 2010, 28:1435-1445.
4. Beeghly-Fadiel A., Long J.R., Gao Y.T., Li C., Qu S., Cai Q., Zheng Y., Ruan Z.X., Levy S.E., Deming S.L., Snoddy J.R., Shu X.O., Lu W., Zheng W. Common MMP-7 polymorphisms and breast cancer susceptibility: a multistage study of association and functionality. Cancer Res. 2008, 68:6453-6459.
5. Beneke S., Burkle A. Poly(ADP-ribosyl)ation in mammalian ageing. Nucleic Acids Res. 2007, 35:7456-7465.
6. Bertram C., Hass R. Cellular responses to reactive oxygen species-induced DNA damage and aging. Biol. Chem. 2008, 389:211-220.
7. Bertram C., Hass R. MMP-7 is involved in the aging of primary human mammary epithelial cells (HMEC). Exp. Gerontol. 2008, 43:209-217.
8. Bertram C., Hass R. Cellular senescence of human mammary epithelial cells (HMEC) is associated with an altered MMP-7/HB-EGF signaling and increased formation of elastin-like structures. Mech. Ageing Dev. 2009, 130:657-669.
9. Bhat-Nakshatri P., Appaiah H., Ballas C., Pick-Franke P., Goulet R., Srour E.F., Badve S., Nakshatri H. SLUG/SNAI2 and tumor necrosis factor generate breast cells with CD44+/CD24- phenotype. BMC Cancer 2010, 10:411.
10. Blaine S.A., Ray K.C., Branch K.M., Robinson P.S., Whitehead R.H., Means A.L. Epidermal growth factor receptor regulates pancreatic fibrosis. Am. J. Physiol. Gastrointest. Liver Physiol. 2009, 297:G434-441.
11. Brenner A.J., Stampfer M.R., Aldaz C.M. Increased p16 expression with first senescence arrest in human mammary epithelial cells and extended growth capacity with p16 inactivation. Oncogene 1998, 17:199-205.
12. Campisi J., d'Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat. Rev. Mol. Cell Biol. 2007, 8:729-740.
13. Carreras I., Rich C.B., Jaworski J.A., Dicamillo S.J., Panchenko M.P., Goldstein R., Foster J.A. Functional components of basic fibroblast growth factor signaling that inhibit lung elastin gene expression. Am. J. Physiol. Lung Cell. Mol. Physiol. 2001, 281:L766-775.
14. Chen J.H., Hales C.N., Ozanne S.E. DNA damage, cellular senescence and organismal ageing: causal or correlative?. Nucleic Acids Res. 2007, 35:7417-7428.
15. Cichon M.A., Degnim A.C., Visscher D.W., Radisky D.C. Microenvironmental influences that drive progression from benign breast disease to invasive breast cancer. J. Mammary Gland Biol. Neoplasia 2010, 15:389-397.
16. Clarke R.B., Spence K., Anderson E., Howell A., Okano H., Potten C.S. A putative human breast stem cell population is enriched for steroid receptor-positive cells. Dev. Biol. 2005, 277:443-456.
17. Das S., Banerji A., Frei E., Chatterjee A. Rapid expression and activation of MMP-2 and MMP-9 upon exposure of human breast cancer cells (MCF-7) to fibronectin in serum free medium. Life Sci. 2008, 82:467-476.
18. d'Adda di Fagagna F., Reaper P.M., Clay-Farrace L., Fiegler H., Carr P., von Zglinicki T., Saretzki G., Carter N.P., Jackson S.P. A DNA damage checkpoint response in telomere-initiated senescence. Nature 2003, 426:194-198.
19. Dimri G.P., Lee X., Basile G., Acosta M., Scott G., Roskelley C., Medrano E.E., Linskens M., Rubelj I., Pereira-Smith O., et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:9363-9367.
20. Dontu G., El-Ashry D., Wicha M.S. Breast cancer, stem/progenitor cells and the estrogen receptor. Trends Endocrin. Metab. 2004, 15:193-197.
21. Gruda M.C., Kovary K., Metz R., Bravo R. Regulation of Fra-1 and Fra-2 phosphorylation differs during the cell cycle of fibroblasts and phosphorylation in vitro by MAP kinase affects DNA binding activity. Oncogene 1994, 9:2537-2547.
22. Harley C.B., Futcher A.B., Greider C.W. Telomeres shorten during ageing of human fibroblasts. Nature 1990, 345:458-460.
23. Hass R. Retrodifferentiation - a mechanism for cellular regeneration?. Biol. Chem. 2009, 390:409-416.
24. Hass R. Rejuvenation in distinct cell populations - what does it mean?. Exp. Gerontol. 2009, 44:634-638.
25. Hass R., Bertram C. Characterization of human breast cancer epithelial cells (HBCEC) derived from long term cultured biopsies. J. Exp. Clin. Cancer Res. 2009, 28:127.
26. Helleman J., Jansen M.P., Ruigrok-Ritstier K., van Staveren I.L., Look M.P., Meijer-van Gelder M.E., Sieuwerts A.M., Klijn J.G., Sleijfer S., Foekens J.A., Berns E.M. Association of an extracellular matrix gene cluster with breast cancer prognosis and endocrine therapy response. Clin. Cancer Res. 2008, 14:5555-5564.
27. Herbert B.S., Wright W.E., Shay J.W. p16(INK4a) inactivation is not required to immortalize human mammary epithelial cells. Oncogene 2002, 21:7897-7900.
28. Huang M., Li Y., Zhang H., Nan F. Breast cancer stromal fibroblasts promote the generation of CD44+ CD24- cells through SDF-1/CXCR4 interaction. J. Exp. Clin. Cancer Res. 2010, 29:80.
29. Hughes S., Agbaje O., Bowen R.L., Holliday D.L., Shaw J.A., Duffy S., Jones J.L. Matrix metalloproteinase single-nucleotide polymorphisms and haplotypes predict breast cancer progression. Clin. Cancer Res. 2007, 13:6673-6680.
30. Huschtscha L.I., Noble J.R., Neumann A.A., Moy E.L., Barry P., Melki J.R., Clark S.J., Reddel R.R. Loss of p16INK4 expression by methylation is associated with lifespan extension of human mammary epithelial cells. Cancer Res. 1998, 58:3508-3512.
31. Ii M., Yamamoto H., Adachi Y., Maruyama Y., Shinomura Y. Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis. Exp. Biol. Med. (Maywood) 2006, 231:20-27.
32. Jones F.E. HER4 intracellular domain (4ICD) activity in the developing mammary gland and breast cancer. J. Mammary Gland Biol. Neoplasia 2008, 13:247-258.
33. Keysar S.B., Jimeno A. More than markers: biological significance of cancer stem cell-defining molecules. Mol. Cancer Ther. 2010, 9:2450-2457.
34. Kim H.J., Kim M.J., Ahn S.H., Son B.H., Kim S.B., Ahn J.H., Noh W.C., Gong G. Different prognostic significance of CD24 and CD44 expression in breast cancer according to hormone receptor status. Breast 2011, 20:78-85.
35. Kitamura T., Biyajima K., Aoki M., Oshima M., Taketo M.M. Matrix metalloproteinase 7 is required for tumor formation, but dispensable for invasion and fibrosis in SMAD4-deficient intestinal adenocarcinomas. Lab. Invest. 2009, 89:98-105.
36. Kiyono T., Foster S.A., Koop J.I., McDougall J.K., Galloway D.A., Klingelhutz A.J. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 1998, 396:84-88.
37. Kuperwasser C., Chavarria T., Wu M., Magrane G., Gray J.W., Carey L., Richardson A., Weinberg R.A. Reconstruction of functionally normal and malignant human breast tissues in mice. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:4966-4971.
38. Lavrentieva A., Majore I., Kasper C., Hass R. Effects of hypoxic culture conditions on umbilical cord-derived human mesenchymal stem cells. Cell Commun. Signal. 2010, 8:18.
39. Leask A. Potential therapeutic targets for cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation. Circ. Res. 2010, 106:1675-1680.
40. Lindley L.E., Briegel K.J. Molecular characterization of TGFbeta-induced epithelial-mesenchymal transition in normal finite lifespan human mammary epithelial cells. Biochem. Biophys. Res. Commun. 2010, 399:659-664.
41. Linggi B., Cheng Q.C., Rao A.R., Carpenter G. The ErbB-4 s80 intracellular domain is a constitutively active tyrosine kinase. Oncogene 2006, 25:160-163.
42. Liu H., Huang J., Wu B., Zhou Y., Zhu J., Zhang T. Matrilysin inhibits proliferation and modulates sensitivity of lung cancer cells to FasL-mediated apoptosis. Med. Oncol. 2008, 25:419-430.
43. Liu J., Rich C.B., Buczek-Thomas J.A., Nugent M.A., Panchenko M.P., Foster J.A. Heparin-binding EGF-like growth factor regulates elastin and FGF-2 expression in pulmonary fibroblasts. Am. J. Physiol. Lung Cell. Mol. Physiol. 2003, 285:L1106-1115.
44. Lu X., Wang Q., Hu G., Van Poznak C., Fleisher M., Reiss M., Massague J., Kang Y. ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis. Genes Dev. 2009, 23:1882-1894.
45. Lynch C.C., Vargo-Gogola T., Martin M.D., Fingleton B., Crawford H.C., Matrisian L.M. Matrix metalloproteinase 7 mediates mammary epithelial cell tumorigenesis through the ErbB4 receptor. Cancer Res. 2007, 67:6760-6767.
46. Majore I., Moretti P., Hass R., Kasper C. Identification of subpopulations in mesenchymal stem cell-like cultures from human umbilical cord. Cell Commun. Signal. 2009, 7:6.
47. Mani S.A., Guo W., Liao M.J., Eaton E.N., Ayyanan A., Zhou A.Y., Brooks M., Reinhard F., Zhang C.C., Shipitsin M., Campbell L.L., Polyak K., Brisken C., Yang J., Weinberg R.A. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008, 133:704-715.
48. Martin F.T., Dwyer R.M., Kelly J., Khan S., Murphy J.M., Curran C., Miller N., Hennessy E., Dockery P., Barry F.P., O'Brien T., Kerin M.J. Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT). Breast Cancer Res. Treat. 2010, 124:317-326.
49. McIntyre E., Blackburn E., Brown P.J., Johnson C.G., Gullick W.J. The complete family of epidermal growth factor receptors and their ligands are co-ordinately expressed in breast cancer. Breast Cancer Res. Treat. 2010, 122:105-110.
50. Mitra A., Chakrabarti J., Chatterjee A. Binding of alpha5 monoclonal antibody to cell surface alpha5beta1 integrin modulates MMP-2 and MMP-7 activity in B16F10 melanoma cells. J. Environ. Pathol. Toxicol. Oncol. 2003, 22:167-178.
51. Muraoka-Cook R.S., Feng S.M., Strunk K.E., Earp H.S. ErbB4/HER4: role in mammary gland development, differentiation and growth inhibition. J. Mammary Gland Biol. Neoplasia 2008, 13:235-246.
52. Naresh A., Long W., Vidal G.A., Wimley W.C., Marrero L., Sartor C.I., Tovey S., Cooke T.G., Bartlett J.M., Jones F.E. The ERBB4/HER4 intracellular domain 4ICD is a BH3-only protein promoting apoptosis of breast cancer cells. Cancer Res. 2006, 66:6412-6420.
53. Narita M., Nunez S., Heard E., Narita M., Lin A.W., Hearn S.A., Spector D.L., Hannon G.J., Lowe S.W. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 2003, 113:703-716.
54. Overholtzer M., Mailleux A.A., Mouneimne G., Normand G., Schnitt S.J., King R.W., Cibas E.S., Brugge J.S. A nonapoptotic cell death process, entosis, that occurs by cell-in-cell invasion. Cell 2007, 131:966-979.
55. Parrinello S., Coppe J.P., Krtolica A., Campisi J. Stromal-epithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation. J. Cell Sci. 2005, 118:485-496.
56. Peinado H., Del Carmen Iglesias-de la Cruz M., Olmeda D., Csiszar K., Fong K.S., Vega S., Nieto M.A., Cano A., Portillo F. A molecular role for lysyl oxidase-like 2 enzyme in snail regulation and tumor progression. EMBO J. 2005, 24:3446-3458.
57. Qian N., Ueno T. Is dysfunction of caveolin-1 a link between systemic sclerosis and breast cancer, opening a window on both etiologies?. Arch. Med. Res. 2010, 41:297-301.
58. Ramirez P.T., Gershenson D.M., Tortolero-Luna G., Ramondetta L.M., Fightmaster D., Wharton J.T., Wolf J.K. Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53. Gynecol. Oncol. 2001, 83:543-548.
59. Renthal N.E., Chen C.C., Williams K.C., Gerard R.D., Prange-Kiel J., Mendelson C.R. miR-200 family and targets, ZEB1 and ZEB2, modulate uterine quiescence and contractility during pregnancy and labor. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:20828-20833.
60. Revillion F., Lhotellier V., Hornez L., Bonneterre J., Peyrat J.P. ErbB/HER ligands in human breast cancer, and relationships with their receptors, the bio-pathological features and prognosis. Ann. Oncol. 2008, 19:73-80.
61. Rich C.B., Fontanilla M.R., Nugent M., Foster J.A. Basic fibroblast growth factor decreases elastin gene transcription through an AP1/cAMP-response element hybrid site in the distal promoter. J. Biol. Chem. 1999, 274:33433-33439.
62. Rinehart C.A., Torti V.R. Aging and cancer: the role of stromal interactions with epithelial cells. Mol. Carcinog. 1997, 18:187-192.
63. Rio C., Buxbaum J.D., Peschon J.J., Corfas G. Tumor necrosis factor-alpha-converting enzyme is required for cleavage of erbB4/HER4. J. Biol. Chem. 2000, 275:10379-10387.
64. Robinet A., Millart H., Oszust F., Hornebeck W., Bellon G. Binding of elastin peptides to S-Gal protects the heart against ischemia/reperfusion injury by triggering the RISK pathway. FASEB J. 2007, 21:1968-1978.
65. Rokicki J., Das P.M., Giltnane J.M., Wansbury O., Rimm D.L., Howard B.A., Jones F.E. The ERalpha coactivator, HER4/4ICD, regulates progesterone receptor expression in normal and malignant breast epithelium. Mol. Cancer 2010, 9:150.
66. Romanov S.R., Kozakiewicz B.K., Holst C.R., Stampfer M.R., Haupt L.M., Tlsty T.D. Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes. Nature 2001, 409:633-637.
67. Rosas I.O., Richards T.J., Konishi K., Zhang Y., Gibson K., Lokshin A.E., Lindell K.O., Cisneros J., Macdonald S.D., Pardo A., Sciurba F., Dauber J., Selman M., Gochuico B.R., Kaminski N. MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis. PLoS Med. 2008, 5:e93.
68. Sánchez-Tilló E., Lázaro A., Torrent R., Cuatrecasas M., Vaquero E.C., Castells A., Engel P., Postigo A. ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI/SNF chromatin-remodeling protein BRG1. Oncogene 2010, 29:3490-3500.
69. Schedin P., Keely P.J. Mammary gland ECM remodeling, stiffness, and mechanosignaling in normal development and tumor progression. Cold Spring Harb. Perspect. Biol. 2011, 3:a003228.
70. Shay J.W., Wright W.E. Telomerase: a target for cancer therapeutics. Cancer Cell 2002, 2:257-265.
71. Shelton D.N., Chang E., Whittier P.S., Choi D., Funk W.D. Microarray analysis of replicative senescence. Curr. Biol. 1999, 9:939-945.
72. Taube J.H., Herschkowitz J.I., Komurov K., Zhou A.Y., Gupta S., Yang J., Hartwell K., Onder T.T., Gupta P.B., Evans K.W., Hollier B.G., Ram P.T., Lander E.S., Rosen J.M., Weinberg R.A., Mani S.A. Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:15449-15454.
73. Tavazoie S.F., Alarcón C., Oskarsson T., Padua D., Wang Q., Bos P.D., Gerald W.L., Massagué J. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 2008, 451:147-152.
74. Taylor M.A., Parvani J.G., Schiemann W.P. The pathophysiology of epithelial-mesenchymal transition induced by transforming growth factor-beta in normal and malignant mammary epithelial cells. J. Mammary Gland Biol. Neoplasia 2010, 15:169-190.
75. Tomé M., López-Romero P., Albo C., Sepúlveda J.C., Fernández-Gutiérrez B., Dopazo A., Bernad A., González M.A. miR-335 orchestrates cell proliferation, migration and differentiation in human mesenchymal stem cells. Cell Death Differ. 2010, [Epub ahead of print].
76. Wadsworth S.J., Atsuta R., McIntyre J.O., Hackett T.L., Singhera G.K., Dorscheid D.R. IL-13 and TH2 cytokine exposure triggers matrix metalloproteinase 7-mediated Fas ligand cleavage from bronchial epithelial cells. J. Allergy Clin. Immunol. 2010, 126:366-374. 374 e361-368.
77. Welte Y., Adjaye J., Lehrach H.R., Regenbrecht C.R. Cancer stem cells in solid tumors: elusive or illusive?. Cell Commun. Signal. 2010, 8:6.
78. Williams C.C., Allison J.G., Vidal G.A., Burow M.E., Beckman B.S., Marrero L., Jones F.E. The ERBB4/HER4 receptor tyrosine kinase regulates gene expression by functioning as a STAT5A nuclear chaperone. J. Cell Biol. 2004, 167:469-478.
79. Yaswen P., Stampfer M.R. Molecular changes accompanying senescence and immortalization of cultured human mammary epithelial cells. Int. J. Biochem. Cell Biol. 2002, 34:1382-1394.
80. Yi Y.C., Chou P.T., Chen L.Y., Kuo W.H., Ho E.S., Han C.P., Yang S.F. Matrix metalloproteinase-7 (MMP-7) polymorphism is a risk factor for endometrial cancer susceptibility. Clin. Chem. Lab. Med. 2010, 48:337-344.
81. Yu Q., Stamenkovic I. Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes Dev. 1999, 13:35-48.
82. Yu W.H., Woessner J.F., McNeish J.D., Stamenkovic I. CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling. Genes Dev. 2002, 16:307-323.
83. Zhang H., Pan K.H., Cohen S.N. Senescence-specific gene expression fingerprints reveal cell-type-dependent physical clustering of up-regulated chromosomal loci. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:3251-3256.
84. Zhu Y., Sullivan L.L., Nair S.S., Williams C.C., Pandey A.K., Marrero L., Vadlamudi R.K., Jones F.E. Coregulation of estrogen receptor by ERBB4/HER4 establishes a growth-promoting autocrine signal in breast tumor cells. Cancer Res. 2006, 66:7991-7998.